CoverMyMeds in Columbus cuts additional teams as restructuring continues three years after 2023 layoffs

New reductions follow 2023 job cuts that reshaped a major Columbus health-technology employer

CoverMyMeds, a Columbus-founded health-technology company owned by McKesson, has cut multiple internal teams in recent days, extending a restructuring cycle that began with large-scale layoffs in 2023. The latest changes were described by affected workers as targeted eliminations across specific groups rather than a single, companywide layoff announcement.

The company remains one of Central Ohio’s most visible healthcare technology employers. CoverMyMeds’ core business centers on tools used by health plans, pharmacies, drug manufacturers and providers to navigate prescription access requirements, including prior authorization and related administrative processes.

What is known about the earlier layoffs

In late March 2023, CoverMyMeds disclosed plans to eliminate about 815 roles. At that time, the company also indicated it would reduce its physical footprint, including changes affecting offices in Columbus and other markets. The 2023 reductions were among the largest corporate layoffs in the Columbus region that year and were framed as a cost-and-investment reset after earlier growth.

What has changed now

The latest round differs in scope and visibility. Rather than a single disclosed figure, the current restructuring has been characterized by discrete team-level cuts, with workers reporting that functions were eliminated or consolidated. No comprehensive public count of impacted positions has been confirmed.

The changes are unfolding as McKesson has been reshaping parts of its organization and reporting structure, with public statements in 2025 outlining shifts to segment organization and corporate structure. Those moves set a context in which subsidiaries and business units may be reorganized, consolidated, or refocused to align with broader operational priorities.

Local impact and workforce uncertainty

For Columbus, the renewed reductions underscore ongoing uncertainty around a company that has been tied to major economic-development expectations and a large local office presence. For workers, repeated rounds of restructuring can create disruption that extends beyond those directly affected, as teams absorb work, projects are reassigned, and hiring plans are revised.

• In 2023, the company said it would eliminate about 815 roles and adjust office space.
• In 2026, workers describe additional team-level eliminations without a single confirmed public total.
• The reductions are occurring amid broader organizational changes at the parent company level.

Companies often execute workforce changes in phases—first through broad layoffs, then through targeted team consolidations—when shifting investment priorities and reorganizing operations.

What to watch next

Key open questions include whether additional teams will be affected, whether the company will file any public workforce notices tied to Ohio employment thresholds, and how the changes will alter the company’s Columbus footprint. Another indicator will be whether CoverMyMeds posts new roles aligned to any strategic shift—such as specialty-therapy support services and platform consolidation—after completing the current restructuring.

For Central Ohio’s technology workforce, the developments are a reminder that health-tech employers can be influenced by national healthcare economics and parent-company portfolio decisions, even when the local brand remains prominent.